Takahiro Nakata
National Defense Medical College
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Takahiro Nakata.
Neuroreport | 2000
Hirotaka Matsuo; Shingo Tsukada; Takahiro Nakata; Arthit Chairoungdua; Do Kyung Kim; Seok Ho Cha; Jun Inatomi; Hiroshi Yorifuji; Jun Fukuda; Hitoshi Endou; Yoshikatsu Kanai
Amino acid transport system L has been proposed to be one of the major nutrient transport systems at the blood–brain barrier. Using immunohistochemical analyses, a system L transporter LAT1 was shown to be expressed in the brain capillary endothelial cells in rats. Because LAT1 was co-expressed with 4F2 heavy chain which brings LAT1 to the plasma membrane, LAT1 is proposed to be functional in the plasma membrane of brain capillary endothelial cells. Both LAT1 and 4F2hc immunoreactivities were detected in a double line appearance surrounding endothelial cell nuclei, suggesting both proteins are present in the luminal and abluminal membranes. LAT1 is, thus, a blood–brain barrier system L transporter responsible for the permeation of aromatic or branched-chain amino acids and amino acid-related drugs such as L-DOPA.
The Journal of Neuroscience | 2011
Yasushi Satoh; Shogo Endo; Takahiro Nakata; Yasushi Kobayashi; Kazuyuki Yamada; Toshio Ikeda; Atsuya Takeuchi; Takeshi Hiramoto; Yasuhiro Watanabe; Tomiei Kazama
Signaling through extracellular signal-regulated kinase (ERK) is important in multiple signal transduction networks in the CNS. However, the specific role of ERK2 in in vivo brain functions is not fully understood. Here we show that ERK2 play a critical role in regulating social behaviors as well as cognitive and emotional behaviors in mice. To study the brain function of ERK2, we used a conditional, region-specific, genetic approach to target Erk2 using the Cre/loxP strategy with a nestin promoter-driven cre transgenic mouse line to induce recombination in the CNS. The resulting Erk2 conditional knock-out (CKO) mice, in which Erk2 was abrogated specifically in the CNS, were viable and fertile with a normal appearance. These mice, however, exhibited marked anomalies in multiple aspects of social behaviors related to facets of autism-spectrum disorders: elevated aggressive behaviors, deficits in maternal nurturing, poor nest-building, and lower levels of social familiarity and social interaction. Erk2 CKO mice also exhibited decreased anxiety-related behaviors and impaired long-term memory. Pharmacological inhibition of ERK1 phosphorylation in Erk2 CKO mice did not affect the impairments in social behaviors and learning disabilities, indicating that ERK2, but not ERK1 plays a critical role in these behaviors. Our findings suggest that ERK2 has complex and multiple roles in the CNS, with important implications for human psychiatric disorders characterized by deficits in social behaviors.
Neuroscience Letters | 2004
Hirotaka Matsuo; Yoshikatsu Kanai; Motohide Tokunaga; Takahiro Nakata; Arthit Chairoungdua; Hisako Ishimine; Shingo Tsukada; Hidetoshi Ooigawa; Hiroshi Nawashiro; Yasushi Kobayashi; Jun Fukuda; Hitoshi Endou
System asc transporter Asc-1, expressed in the brain, transports D- and L-serine with high affinity. To determine the localization of Asc-1 in the rat brain, we isolated a cDNA for the rat orthologue of Asc-1. The encoded protein designated as rAsc-1 (rat Asc-1) exhibited 98% sequence identity to mouse Asc-1 (mAsc-1). Based on amino acid sequences of rAsc-1 and mAsc-1, two polyclonal antibodies against Asc-1 were generated and used for the immunohistochemical analysis on the cerebral and cerebellar cortices of rats and mice. Asc-1 immunoreactivity was detected in neurons, including cerebellar Purkinje neurons and pyramidal neurons in the neocortex and hippocampus. It was clearly localized in dendrites as well as somata. The localization of Asc-1 in brain suggests the significant contribution of Asc-1 to amino acid mobilization in brains including the synaptic clearance of D-serine and the neuronal uptake of L-serine that is essential for survival and dendrite growth of Purkinje neurons in particular.
Neuroscience Research | 1999
Takahiro Nakata; Hiroshi Yorifuji
The short term effects of taxol, a stabilizing drug of microtubules, on the peripheral nerves in the rat was investigated using a new chamber system which can be applied to incubate a sciatic nerve with various solutions in vivo. A functional analysis of retrograde axonal transport using rhodamine-labeled wheat germ agglutinin (WGA-rhodamine) showed the inhibitory effect of the drug. An electron microscopic study also revealed that a variety of vesicles were observed to accumulate on both the proximal and the distal sides of the chamber, however, no significant increase in the number of microtubules in the axons, based on the pharmacological effect of the drug, was observed even though one had been expected. These findings support the inhibitory effect of taxol on the fast axonal transport of the neurons. Furthermore, the accumulated vesicles were morphologically different from those accumulated by ligation. These results suggest that a special component of the fast axonal transport was thus selectively blocked by the drug.
Neuroscience | 2013
Takahiro Nakata; Toshiyasu Matsui; K. Kobayashi; Yasushi Kobayashi; Naohiko Anzai
Organic cation transporters (OCTs) are expressed mainly in the kidney and liver. OCTs transport intrinsic organic cations, including monoamine, dopamine, serotonine and choline, across the plasma membrane. Here, we demonstrate that OCT2 (SLC22A2) is expressed in cholinergic neurons, motoneurons in the anterior horn of the spinal cord, and is implicated in acetylcholine (Ach) recycling in presynaptic terminals. Application of rabbit anti-peptide antibody revealed that OCT2 was expressed in the anterior horn of the spinal cord. Double immunostaining of muscle sections with anti-OCT2 and alpha-bungarotoxin (BTX) revealed that OCT2 was localized in the neuromuscular junctions (NMJs). Immunoelectron microscopy revealed that OCT2 was localized both in synaptic vesicles (SVs) in presynaptic terminals around the motoneurons (C-terminals) and in SVs in nerve terminals in NMJs. The similarity in the distribution of OCT2 in cholinergic neurons and that of vesicular acetyl choline transporter (VAchT), and the fact that OCT2 can transport choline suggest that OCT2 could work as a low-affinity and high-capacity choline transporter at presynaptic terminals in cholinergic neurons in a firing-dependent manner.
Oncology Reports | 2011
Tatsuya Shiraki; Eiji Takayama; Hirohito Magari; Takahiro Nakata; Takao Maekita; Shotaro Enomoto; Yoshiyuki Mori; Naoki Shingaki; Kosaku Moribata; Hisanobu Deguchi; Kazuki Ueda; Izumi Inoue; Masako Mizuno-Kamiya; Koji Yashiro; Mikitaka Iguchi; Hideyuki Tamai; Yasunaga Kameyama; Jun Kato; Nobuo Kondoh; Masao Ichinose
Although CD57+ lymphocytes are closely correlated with prognosis in various cancers, the role of subsets of CD57+ cells in hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) is unclear. In the present study, peripheral blood (PB) from HCV-related HCC patients was analyzed. Plasma cytokine levels and in vitro cytokine-producing capabilities were analyzed with enzyme-linked immunosorbent assays, and CD57+ cell subsets were studied using a multi-color FACS system. Interferon (IFN)-γ was undetectable in the plasma of patients with tumors at any stage, whereas the plasma levels of tumor necrosis factor (TNF)-α, interleukin (IL)-10 and IL-18, but not that of IL-12, were significantly higher in stage IV patients compared to patients with earlier-stage tumors. In contrast, the IFN-γ-producing capability of PB was highest in stage I patients and gradually decreased with tumor progression. The IL-10-, IL-18- and IL-12-producing capabilities of PB increased from stage I to III. However, PB-TNF-α, IL-10- and IL-18-producing capabilities were reduced in stage IV patients, probably due to repeated anti-cancer treatments. The percentage of CD4+CD57+αβTCR+ cells (CD4+CD57+ T cells) in peripheral blood lymphocytes (PBLs) increased with tumor progression. Moreover, the percentage of CD4+CD57+ T cells in PBLs and the ratio of CD4+CD57+ T cells to CD4+αβTCR+ cells (CD4+ T cells), but not that of CD4+CD57+ T cells to CD57+αβTCR+ cells (CD57+ T cells), showed a significant inverse correlation with PB-IFN-γ-producing capability. The present results suggest that an increase in CD4+CD57+ T cells controls the capability of PB to produce the anti-tumor cytokine IFN-γ and that PB-IFN-γ production is impaired with HCC tumor progression.
Neuroscience Research | 1997
Takahiro Nakata; Hiroshi Yorifuji
KEN IMAI’, HITOSHI TA4TSUMI’,3, YOSHIFUMI K.4TAYAMA1 In the present study, we developed an experimental system to investigate which sites of a single neuron are sensitive to mechanical pressure or deformity, by using cultured rat dorsal root ganglion (DRG) cells. Neonatal rats were anesthetized and DRG cells were isolated, then plated. 2 to 48 hours after plating, growth cones were observed at the tip of the neurites with a V-DIC microscope. Highly-precised mechanical stimulation was applied to various sites of the cells? using a piezo-driven glass microcapillary whose movement was computercontrolled. When the growth cones were stimulated at the holding potential of -6OmV, inward currents were recorded when whole-cell patch clamp recordings were made at cell bodies. Almost no electrical responses were recorded when other sites of DRG cells were mechanically stimulated. Although the time course and amplitude of these evoked inward currents were different from cell to cell, evoked inward currents usually appeared to consist of two phases; initial transient phase of lOO-200msec and following long-lasting phase up to several seconds. When the holding potentials were shifted from -60 mV to 0 mV, evoked currents turned outward.
Biochemical and Biophysical Research Communications | 2001
Takahiro Nakata; Yasushi Nishina; Hiroshi Yorifuji
Glycobiology | 1998
Mariko Kudo; Eiji Takayama; Kosuke Tashiro; Hiroshi Fukamachi; Takahiro Nakata; Takushi Tadakuma; Ken Kitajima; Yasuo Inoue; Koichiro Shiokawa
Oncology Reports | 2017
Junko Masuda; Eiji Takayama; Warren Strober; Ayano Satoh; Yuji Morimoto; Yasuko Honjo; Tatsuo Ichinohe; Shin Ichi Tokuno; Toshiaki Ishizuka; Takahiro Nakata; Akifumi Mizutani; Naoki Umemura; Atsushi Kitani; Ivan J. Fuss; Tsukasa Shigehiro; Harumi Kawaki; Masako Mizuno-Kamiya; Nobuo Kondoh; Masaharu Seno